1. |
Wang J, Meng W. COVID-19 and Diabetes: the Contributions of Hyperglycemia. J Mol Cell Biol, 2020, 12(12): 958-962.
|
2. |
Rajpal A, Rahimi L, Ismail-Beigi F. Factors Leading to High Morbi dity and Mortality of COVID-19 in Patients with Type 2 Diabetes. J Diabetes, 2020, 12(12): 895-908.
|
3. |
Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet, 2007, 370(9589): 786-796.
|
4. |
Sapey E, Stockley RA. COPD exacerbations· 2: aetiology. Thorax, 2006, 61(3): 250-258.
|
5. |
Poucineau J, Delory T, Lapidus N, et al. Hospital admissions and mortality for acute exacerbations of COPD during the COVID-19 pandemic: A nationwide study in France. Front Med(Lausanne), 2022, 9: 995016.
|
6. |
Saeed MI, Sivapalan P, Eklöf J, et al. Social distancing in relation to severe exacerbations of chronic obstructive pulmonary disease: a nationwide semi-experimental study during the COVID-19 pandemic. Am J Epidemiol, 2022, 191(5): 874-885.
|
7. |
Chan KPF, Ma TF, Kwok WC, et al. Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic. Respir Med, 2020, 171: 106085.
|
8. |
Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020, 382(18): 1708-1720.
|
9. |
Metz C, Schmid A, Veldhoen S. Increase in complicated upper respiratory tract infection in children during the 2022/2023 winter season—a post coronavirus disease 2019 effect? Pediatr Radiol, 2024, 54(1): 49-57.
|
10. |
Abushahin A, Toma H, Alnaimi A, et al. Impact of COVID-19 pandemic restrictions and subsequent relaxation on the prevalence of respiratory virus hospitalizations in children. BMC pediatr, 2024, 24(1): 91.
|
11. |
Wang H, Fu M, Chen W, et al. Post-COVID-19 pandemic changes in pertussis incidence among patients with acute respiratory tract infections in Zhejiang, China. Fron Microbiol, 2024, 15: 1448997.
|
12. |
Xu Y, Yang C, Sun P, et al. Epidemic Features and Megagenomic Analysis of Childhood Mycoplasma Pneumoniae post COVID-19 Pandemic: A 6-year Study in Southern China. Emerg Microbes Infect, 2024, 13(1): 2353298.
|
13. |
You J, Zhang L, Chen W, et al. Epidemiological characteristics of mycoplasma pneumoniae in hospitalized children before, during, and after COVID-19 pandemic restrictions in Chongqing, China. Front Cell Infect Microbiol, 2024, 14: 1424554.
|
14. |
Li H, Yang Y, Tao R, et al. Analyzing infections caused by 11 respiratory pathogens in children: Pre‐and post‐COVID‐19 pandemic trends in China. J Med Virol, 2024, 96(9): e29929.
|
15. |
Halpin DMG, Vogelmeier CF, Agusti AA. Copd & covid-19. Arch Bronconeumol(Engl Ed), 2021, 57(3): 162-164.
|
16. |
Higham A, Mathioudakis A, Vestbo J, et al. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes. Eur Respir Rev, 2020, 29(158): 200199.
|
17. |
Halpin DMG, Faner R, Sibila O, et al. Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection? Lancet Respir Med. 2020, 8(5): 436–438.
|
18. |
Mohan A, Chandra S, Agarwal D, et al. Prevalence of viral infection detected by PCR and RT‐PCR in patients with acute exacerbation of COPD: a systematic review. Respirology, 2010, 15(3): 536-542.
|
19. |
Du XB, Ma X, Gao Y, et al. Prevalence and risk factors of respiratory viral infection in acute exacerbation of chronic obstructive pulmonary disease. Chinese Journal of Tuberculosis and Respiratory Diseases, 2017, 40(4): 263-266.
|
20. |
Galli J, Sheppard SC, Caversaccio M, et al. Correction: Impact of COVID-19 pandemic: increase in complicated upper respiratory tract infections requiring ENT surgery?Eur Arch Otorhinolaryngol, 2024, 281(3): 1587.
|
21. |
Jafarinejad H, Moghoofei M, Mostafaei S, et al. Worldwide prevalence of viral infection in AECOPD patients: a meta-analysis. Microb pathog, 2017, 113: 190-196.
|
22. |
杜小兵, 马旭, 高杨, 等. 慢性阻塞性肺疾病急性加重期呼吸道病毒感染检出率及危险因素分析. 中华结核和呼吸杂志, 2017, 40(4): 263-266.
|
23. |
Cheon IS, Son YM, Sun J. Tissue‐resident memory T cells and lung immunopathology. Immunol Rev, 2023, 316(1): 63-83.
|